ERD

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Meta...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

From NASH to HCC: current concepts and future challenges

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Lipidomes in health and disease: Analytical strategies and considerations

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in P...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with se...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Genetics of Alcoholic Liver Disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-r...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disea...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Determinants of fibrosis progression and regression in NASH

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systemati...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Glucose kinetics

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingo...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver dis...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Resources

Selected filters:

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Meta...

From NASH to HCC: current concepts and future challenges

Lipidomes in health and disease: Analytical strategies and considerations

qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in P...

Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with se...

Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis

Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

Genetics of Alcoholic Liver Disease

Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD

Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-r...

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disea...

Determinants of fibrosis progression and regression in NASH

NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systemati...

Glucose kinetics

Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingo...

Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver dis...

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases